During Q4 2018 the big money sentiment decreased to 0.9. That’s change of 0.14, from 2018Q3’s 1.04. 64 investors sold all, 190 reduced holdings as IDXX ratio turned negative. 166 rose stakes while 63 funds acquired stakes. Funds hold 73.87 million shares thus 4.58% more from 2018Q3’s 70.63 million shares. State Board Of Administration Of Florida Retirement accumulated 124,604 shs. Nordea Inv Mngmt Ab invested in 0% or 4,445 shs. State Of Alaska Department Of Revenue owns 19,228 shs for 0.07% of their capital. Shine Inv Advisory has invested 0.02% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). State Street Corp stated it has 0.06% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Private Advisor Group Incorporated Limited Co holds 0.01% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 2,697 shs. Ww Asset Inc has invested 0.06% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Zebra Capital Mgmt accumulated 2,404 shs. Metropolitan Life Ins stated it has 0.07% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Ameritas Ptnrs reported 3,163 shs. Calamos Advsr Limited Liability Corp stated it has 19,681 shs or 0.02% of all its holdings. Gotham Asset Mngmt Ltd Liability Corporation has 5,413 shs for 0.02% of their capital. Wall Street Access Asset Management Lc has 2,274 shs for 0.68% of their capital. Valmark Advisers stated it has 0.01% of its capital in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Marshall Wace Llp accumulated 0.3% or 158,616 shs.

IDXX registered $10.91 million net activity with 1 insider buy and 4 insider sales since November 6, 2018. On Tuesday, February 5 $501,875 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was bought by Kingsley Lawrence D. Studer Jacqueline also sold $666,823 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shs. AYERS JONATHAN W sold $9.85M worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 47,714 shs on Tuesday, February 5. HENDERSON REBECCA M also sold $682,992 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shs.

In Idexx Labs Inc (IDXX) was decreased the stake owned by Howland Capital Management Llc. The decrease is 11.16% according to 2018Q4 SEC form. By selling 19,989 shares Howland Capital Management Llc made the stock popped up with 5.43%. The institutional investor is holding 159,092 shares, compared to the 179,081 from the previous quarter. And the reported value of the health care company is $29.59M for the 2018Q4. For a total of 433,350 shares it increased its holding in Tjx Cos Inc New (NYSE:TJX) by 212,080 shares in the quarter, and has risen its stake in Janus Detroit Str Tr.

Earnings report for IDEXX Laboratories, Inc. (NASDAQ:IDXX) is anticipated on May, 3., according to Faxor. Analysts have expectation on stock’s earnings per share of $1.04. That’s up 2.97 % from last year’s $1.01 earnings per share. In case of $1.04 earnings per share IDXX’s profit could reach $89.48M. 6.12 % EPS growth is what analysts predict. $0.98 earnings per share was revealed for previous quarter.

For more IDEXX Laboratories, Inc. (NASDAQ:IDXX) news released recently go to: Nasdaq.com, Nasdaq.com, Nasdaq.com, Nasdaq.com or Nasdaq.com. The titles are as follows: “Here’s Why You Should Invest in AngioDynamics Stock Now – Nasdaq” released on March 05, 2019, “IDEXX (IDXX) Q4 Earnings Top Estimates, Raises ’19 EPS View – Nasdaq” on February 01, 2019, “Here’s Why You Should Retain Patterson Companies (PDCO) Stock – Nasdaq” with a publish date: March 20, 2019, “Here’s Why You Should Invest in Integer Holdings (ITGR) Stock – Nasdaq” and the last “Implied VO Analyst Target Price: $176 – Nasdaq” with publication date: March 28, 2019.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Ratings Coverage

Total analysts of 2 have positions in IDEXX Laboratories (NASDAQ:IDXX) as follows: 2 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since November 2, 2018 according to StockzIntelligence Inc IDEXX Laboratories has 3 analyst reports. On Monday, November 5 the firm has “Buy” rating given by Canaccord Genuity. On Tuesday, March 26 the rating was maintained by Canaccord Genuity with “Buy”. In Friday, November 2 report Bank of America maintained the stock with “Buy” rating.